packageEnzalutamide

enzalutamide

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Enzalutamide is an anti-androgen medicine used to treat prostate cancer. It is an approved drug and is authorised in the European Union for prostate tumours.

Summary written by glm-5.3-flash from Wikidata Q1996756 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:enzalutamide
ATC codes:L02BB04
DrugBank:DB08899
PubChem CID:15951529
ChEBI:68534
Wikidata:Q1996756
formula:C21H16F4N4O2S
molar mass:464.437 g/mol (PubChem CID 15951529)
logP:3.6 (Drugs.Common 25.09, not verified)

Metabolites

NDesmethylEnzalutamideN-desmethyl enzalutamide450.41 g/mol (pubchem)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown

Contents

NameDescription
NDesmethylEnzalutamidemetabolite: N-desmethyl enzalutamide